ATE340170T1 - S-omeprazol-magnesiumsalz - Google Patents

S-omeprazol-magnesiumsalz

Info

Publication number
ATE340170T1
ATE340170T1 AT03253070T AT03253070T ATE340170T1 AT E340170 T1 ATE340170 T1 AT E340170T1 AT 03253070 T AT03253070 T AT 03253070T AT 03253070 T AT03253070 T AT 03253070T AT E340170 T1 ATE340170 T1 AT E340170T1
Authority
AT
Austria
Prior art keywords
magnesium salt
omeprazole
omeprazole magnesium
enantiomer
solvent
Prior art date
Application number
AT03253070T
Other languages
English (en)
Inventor
Bernard Charles Sherman
Original Assignee
Bernard Charles Sherman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29555354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE340170(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bernard Charles Sherman filed Critical Bernard Charles Sherman
Application granted granted Critical
Publication of ATE340170T1 publication Critical patent/ATE340170T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT03253070T 2002-05-17 2003-05-16 S-omeprazol-magnesiumsalz ATE340170T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2386716A CA2386716C (en) 2002-05-17 2002-05-17 Magnesium salt of s-omeprazole

Publications (1)

Publication Number Publication Date
ATE340170T1 true ATE340170T1 (de) 2006-10-15

Family

ID=29555354

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03253070T ATE340170T1 (de) 2002-05-17 2003-05-16 S-omeprazol-magnesiumsalz

Country Status (5)

Country Link
EP (1) EP1375497B1 (de)
JP (1) JP2004002422A (de)
AT (1) ATE340170T1 (de)
CA (1) CA2386716C (de)
DE (1) DE60308450T2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US7612098B2 (en) 2002-08-30 2009-11-03 Dr. Reddy's Laboratories Limited Amorphous hydrous esomeprazole magnesium
EA200500673A1 (ru) * 2002-10-22 2005-12-29 Рэнбакси Лабораториз Лимитед Аморфная форма соли эзомепразола, способ ее получения и фармацевтическая композиция на её основе
WO2005082888A1 (en) * 2004-03-01 2005-09-09 Milen Merkez Ilac Endustrisi A.S. Process for the preparation of magnesium salt of omeprazole
ES2246149B1 (es) * 2004-07-02 2007-06-01 Esteve Quimica, S.A. Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.
EP1801110A1 (de) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Argininsalz des Esomeprazols
EP1947099A1 (de) * 2007-01-18 2008-07-23 LEK Pharmaceuticals D.D. Verfahren zur Entfernung von Lösungsmitteln in Omeprazol-Salzen
EP2147918A1 (de) 2008-07-21 2010-01-27 LEK Pharmaceuticals D.D. Verfahren zur Herstellung von S-Omeprazol-Magnesium in einer stabilen Form
CN116102538A (zh) * 2023-01-29 2023-05-12 山东省分析测试中心 一种转晶制备三水合艾司奥美拉唑镁的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
CA2290893C (en) * 1999-11-16 2007-05-01 Bernard Charles Sherman Magnesium omeprazole

Also Published As

Publication number Publication date
EP1375497B1 (de) 2006-09-20
JP2004002422A (ja) 2004-01-08
CA2386716C (en) 2012-07-24
DE60308450D1 (de) 2006-11-02
DE60308450T2 (de) 2007-05-10
CA2386716A1 (en) 2003-11-17
EP1375497A1 (de) 2004-01-02

Similar Documents

Publication Publication Date Title
JP2004506350A5 (de)
NO20053099D0 (no) Fremgangsmate for a fremstille optisk rene aktive forbindelser.
ATE340170T1 (de) S-omeprazol-magnesiumsalz
ATE518821T1 (de) Verfahren zur herstellung von alkenonethern
EP1787991A4 (de) Pyrrolo[2,3-c]pyridinverbindung, verfahren zu deren herstellung und anwendung
IS2674B (is) Aðferð við framleiðslu á handhverfulega hreinu mírtasapíni
ATE302744T1 (de) Verfahren zur herstellung von 1-menthol
ATE513840T1 (de) Verfahren zur herstellung optisch aktiver diphosphane
ATE352549T1 (de) Verfahren zur herstellung von desloratadin
ATE369357T1 (de) Verfahren zur herstellung von pantoprazol und seinen salzen
ATE443709T1 (de) Verfahren zur herstellung von 9,10-dihydro-9-oxa- 10-organyl-oxyphosphaphenanthren-10-oxid oder - thion und an den phenylgruppen substituierten derivativen desselben
ITMI20030150A1 (it) Processo per preparare fluoroalogenoeteri.
DE502006007059D1 (de) Racematspaltung von 2,6-trans-dimethylmorpholin
ATE365739T1 (de) Verfahren zur herstellung optisch aktiver 3- chinuclidinole
ATE415388T1 (de) Verfahren zur herstellung von enantiomerenreinen 4-pyrrolidinophenyl- benzyletherderivaten
ATE412613T1 (de) Verfahren zur herstellung von aluminiumtrihydraten mit hohem porenvolumen
ATE540961T1 (de) Furanosederivate fuer die herstellung von atorvastatin
DE602005026991D1 (de) Verfahren zur herstellung von 5-(dicarboximido)levulinsäurealkylestern und 4-oxo-pentensäurealkylestern
TH86861EX (th) อุปกรณ์สื่อสารข้อมูล
ATA13612004A (de) Kleines taschengerät zur herstellung von kolloidalem silber
UY27693A1 (es) Procedimiento para la síntesis de cloroadenosina y metiltioadenosina.
TH98055EX (th) รถยนต์
CY1110479T1 (el) Μια μεθοδος δια την παρασκευη μιας 10,11- διυδρο- 10- υδροξυ - 5η-διβενζ [bf] αζεπινο- 5- καρβοξυαμιδης
TH83402EX (th) ส่วนประกอบของเครื่องเสียง
TH92973EX (th) รถแทร็กเตอร์

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties